- published: 15 Mar 2015
- views: 5986
A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing micro-organism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and keep a record of it, so that the immune system can more easily recognize and destroy any of these micro-organisms that it later encounters. Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by any natural or "wild" pathogen), or therapeutic (e.g., vaccines against cancer are also being investigated).
The administration of vaccines is called vaccination. The effectiveness of vaccination has been widely studied and verified; for example, the influenza vaccine, the HPV vaccine, and the chicken pox vaccine. Vaccination is the most effective method of preventing infectious diseases; widespread immunity due to vaccination is largely responsible for the worldwide eradication of smallpox and the restriction of diseases such as polio, measles, and tetanus from much of the world. The World Health Organization (WHO) reports that licensed vaccines are currently available to prevent or contribute to the prevention and control of twenty-five infections.
Develop or DEVELOP may refer to:
An HIV vaccine is a vaccine which would either protect individuals who do not have HIV from contracting that virus, or otherwise may have a therapeutic effect for persons who have or later contract HIV/AIDS. Currently, there is no effective HIV vaccine but many research projects managing clinical trials seek to create one. There is evidence that a vaccine may be possible. Work with monoclonal antibodies (MAb) has shown or proven that the human body can defend itself against HIV, and certain individuals remain asymptomatic for decades after HIV infection. Potential candidates for antibodies and early stage results from clinical trials have been announced.
One HIV vaccine candidate which showed some efficacy was studied in RV 144, which was a trial in Thailand beginning in 2003 and first reporting a positive result in 2009. Many trials have shown no efficacy, including the STEP study and HVTN 505 trials.
The urgency of the search for a vaccine against HIV stems from the AIDS-related death toll of over 25 million people since 1981. Indeed, in 2002, AIDS became the primary cause of mortality due to an infectious agent in Africa.
The CBS Evening News is the flagship evening television news program of CBS News, the news division of the CBS television network in the United States. The program has been broadcast since 1948 under the original title CBS Television News, eventually adopting its current title in 1963. Since June 6, 2011, the weekday editions of the program have been anchored by Scott Pelley. Since 2012, Jim Axelrod has served as anchor of the Saturday edition, while Jeff Glor anchors the Sunday edition. Previous anchors have included Douglas Edwards, Walter Cronkite, Dan Rather, Bob Schieffer, and Katie Couric.
The program's Monday through Friday editions air live at 6:30 PM in the Eastern and 5:30 PM in the Central Time Zones, and are tape delayed for the Mountain Time Zone. A separate "Western Edition", featuring updated segments to provide coverage of breaking news stories, airs live at 6:30 p.m. in the Pacific Time Zone and on tape delay in the Alaska and Hawaii–Aleutian Time Zones.
Evening News may refer to:
http://yourekascience.org/portfolio/vaccines-101-what-will-it-take-to-develop-an-hiv-vaccine/ What are the challenges to developing an HIV vaccine? How do vaccines work and what are they made of? And come to think of it, how do we know that they work at all! Find out the answers to all of these questions and more in this HIV vaccine video, produced by Youreka Science in collaboration with Bridge HIV of the San Francisco Department of Public Health.
We've learned a bit about how hummingbirds see motion in an unexpected way, and scientists are working on a potential new malaria vaccine by genetically manipulating the parasite that causes it! Hosted by: Hank Green ---------- Support SciShow by becoming a patron on Patreon: https://www.patreon.com/scishow ---------- Dooblydoo thanks go to the following Patreon supporters—we couldn't make SciShow without them! Shout out to Jeremy Peng, Kevin Bealer, Mark Terrio-Cameron, KatieMarie Magnone, Patrick Merrithew, Charles Southerland, Fatima Iqbal, Benny, Kyle Anderson, Tim Curwick, Scott Satovsky Jr, Will and Sonja Marple, Philippe von Bergen, Bella Nash, Bryce Daifuku, Chris Peters, Saul, Patrick D. Ashmore, Charles George, Bader AlGhamdi ---------- Like SciShow? Want to help support us, and...
http://yourekascience.org/portfolio/clinical-trials-101-how-do-we-develop-and-test-a-vaccine/ In this video,we describe the clinical trial process and what it takes to bring an effective vaccine to the population at large. What is a double-blind study? What is placebo? What is the difference between drugs in phase 1, 2, and 3? How long do clinical trials take? Why do we need clinical trials? What is informed consent? Find the answer to all of these questions and more! This video was produced in collaboration with the SF Department of Public Health and Bridge HIV.
NIAID Director Anthony S. Fauci, M.D., discusses the challenges facing development of a safe and effective vaccine to prevent HIV infection.
View full lesson: http://ed.ted.com/lessons/how-do-vaccines-work-kelwalin-dhanasarnsombut The first ever vaccine was created when Edward Jenner, an English physician and scientist, successfully injected small amounts of a cowpox virus into a young boy to protect him from the related (and deadly) smallpox virus. But how does this seemingly counterintuitive process work? Kelwalin Dhanasarnsombut details the science behind vaccines. Lesson by Kelwalin Dhanasarnsombut, animation by Cinematic.
Today's Alternative News Channel - Scientists Develop Vaccine That Brings Dead People Back To Life Scientists have developed the world’s first vaccine that is capable of bringing dead people back to life, using advanced stem cell technology. Bioquark CEO Ira Pastor says his firm has developed injections Source: http://yournewswire.com/vaccine-dead-people/ See our playlist for additional information: POLITICS: https://www.youtube.com/playlist?list=PL3vNhMt4w_SI_yFQvfelBTllKUpszHtGt HEALTH NEWS: https://www.youtube.com/playlist?list=PL3vNhMt4w_SKrC2qOLET6ydlt3Lvx29i_ TECH AND SCIENCE STUFF: https://www.youtube.com/playlist?list=PL3vNhMt4w_SKhC5M0NKTePMwwwezcPFjL Today's Alternative News https://www.youtube.com/channel/UCV6WBPEdQPZAVddWfmk1-Dg https://youtu.be/QdGO9g2xbgM june...
Did you know that vaccine manufacture can take anywhere between 6 and 26 months? That’s not to mention the time required to research and develop a new vaccine which can take up to 30 years. Add to that between 100 and 500 quality checks throughout the process and you start to have an idea of the complexity involved. Take a quick tour through the stages of vaccine manufacture from development to distribution and learn more about a process which produced 690 million doses in 2015 – enough to help protect over a quarter of a million people in around 90% of the world’s countries. GSK - Do more, feel better, live longer. Find out more on http://www.gsk.com Follow @GSK on Twitter: http://twitter.com/GSK Like GSK on Facebook: http://www.facebook.com/GSK Follow GSK on LinkedIn: http://www.linke...
Less than half of Americans got a flu shot last year. Researchers in Atlanta want to increase those numbers by giving people the option to vaccinate themselves -- with a skin patch. Dr. Jon LaPook reports. Subscribe to the "CBS Evening News" Channel HERE: http://bit.ly/1S7Dhik Watch Full Episodes of the "CBS Evening News" HERE: http://cbsn.ws/23XekKA Watch the latest installment of "On the Road," only on the "CBS Evening News," HERE: http://cbsn.ws/23XwqMH Follow "CBS Evening News" on Instagram: http://bit.ly/1T8icTO Like "CBS Evening News" on Facebook HERE: http://on.fb.me/1KxYobb Follow the "CBS Evening News" on Twitter HERE: http://bit.ly/1O3dTTe Follow the "CBS Evening News" on Google+ HERE: http://bit.ly/1Qs0aam Get your news on the go! Download CBS News mobile apps HERE: http://cbs...
London, Ontario CANADA --The first and only preventative HIV vaccine based on a genetically modified killed whole virus has received approval by the United States Food and Drug Administration (FDA) to start human clinical trials. Developed by Dr. Chil-Yong Kang and his team at The University of Western Ontario, with the support of Sumagen Canada, the vaccine (SAV001) holds tremendous promise, having already proven to stimulate strong immune responses in preliminary toxicology tests with no adverse effects or safety risks. It is the only HIV vaccine currently under development in Canada, and one of only a few in the world.
In the 1980’s, the HIV-AIDS virus was considered a death sentence to those who contracted the disease. But things have improved dramatically thanks to drug therapies. However, researchers are still working on developing an HIV vaccine. And as CGTN’s May Lee reports, a new discovery connected to an unusual source could be the breakthrough scientists need. Watch CGTN LIVE on your computer, tablet or mobile http://america.cgtn.com/livenews Subscribe to CGTN America on YouTube Follow CGTN America: Twitter: @cgtnamerica Facebook: @cgtnamerica Google+: CctvamericaTvnews »» Watch CGTN «« Washington, DC (and greater area) • MHz - Channel 3 • COMCAST (Xfinity) - Channel 273 • FIOS - Channel 277 New York City • Time Warner - Channel 134 • FiOS (Verizon) - Channel 277 Los Angeles •...
Influenza kills about a half million people each year, but scientists say a universal flu vaccine might drastically change that. Learn more about this story at www.newsy.com/72291/ Find more videos like this at www.newsy.com Follow Newsy on Facebook: www.facebook.com/newsyvideos Follow Newsy on Twitter: www.twitter.com/newsyvideos
DJ Akademiks speaks on a Scholar who came out the depths of Chiraq named Kevem Stonewall who is on the verge of trying to develop a vaccine for Colon Cancer
While significant progress has been made in the global battle against HIV/AIDS, there is much more that needs to be done to prevent the two million new HIV infections that occur each year. Our hope, our dream is to develop an HIV vaccine that has the potential to prevent HIV and liberate communities from HIV for good. Working together with partners around the world we are uniting to make an HIV-free world a reality. Learn more at jnj.com/AIDS2016 Subscribe to JNJ on YouTube: http://www.youtube.com/subscription_center?add_user=JNJHealth J&J; on Google Plus: http://plus.google.com/+JNJ J&J; on Facebook: http://www.facebook.com/jnj JNJ Cares on Twitter: http://www.twitter.com/jnjcares Our News Center: http://www.jnj.com/our-news-center
Hate needles? Researchers may have found a way to combine all the vaccines you'll ever need into a single shot. Here's how it works. The Bizarre Story Of The Very First Vaccine - https://youtu.be/fF5-aJ-o0Os Sign Up For The Seeker Newsletter Here - http://bit.ly/1UO1PxI Read More: One vaccine injection could carry many doses http://news.mit.edu/2017/one-vaccine-injection-could-carry-many-doses-0914 "MIT engineers have invented a new 3-D fabrication method that can generate a novel type of drug-carrying particle that could allow multiple doses of a drug or vaccine to be delivered over an extended time period with just one injection." How Cow Antibodies Are Helping Scientists Develop an HIV Vaccine https://www.seeker.com/health/medicine/how-the-immune-response-of-cows-is-...
Shan Lu, MD, PhD, professor of medicine at the University of Massachusetts Medical School, has received $17.3 million from the National Institute of Allergy and Infectious Diseases (NIAID) to develop and produce an optimized HIV vaccine to be used in Phase II human clinical trials. The seven-year program builds on two decades of scientific progress by Dr. Lu, a leader in HIV vaccine research, and marks a major milestone in the field of HIV vaccine development.
Finnish scientists have developed a series of allergy vaccines that can revolutionize the treatment of allergies. For more news from Headlines Today visit https://www.youtube.com/channel/UCZdjh94PIFy6fDekDtWRRJQ
Q & A: Dr. John Sinnott on Swine Flu As the number of cases and deaths from swine flu grow and extend beyond North America, health officials across the country, including Florida, prepare for the worst-case scenario -- a full-scale global flu epidemic. In the following interview, Dr. John Sinnott, professor of medicine and chief of infectious diseases at USF Health and Tampa General Hospital, answers questions about swine flu and outlines precautions the public can take.
We need to develop a safe vaccine. Just because a vaccine "works" for a year does not mean it is safe. There are no safe vaccines today. Free homes. Require Utilities pay $.49kwh for solar=$2K/ mo. Build 100 solar panel carports. Solar pays mortgage
Scientists develop a vaccine that protects AIDS from Ebola SUBSCRIBE to our YouTube channel for more great videos: https://www.youtube.com/KTNkenya Follow us on Twitter: https://twitter.com/KTNNews Like us on Facebook: https://www.facebook.com/KTNNewsKenya For more great content go to http://www.standardmedia.co.ke/ktnnews and download our apps: http://std.co.ke/apps/#android KTN News is a leading 24-hour TV channel in Eastern Africa with its headquarters located along Mombasa Road, at Standard Group Centre. This is the most authoritative news channel in Kenya and beyond.
Meet the Johnson & Johnson scientists developing vaccines to stop infectious diseases. Content by Johnson & Johnson
UTMB Sealy Center for Vaccine Development: Vaccine Smarts 3
Learn more about herpes simplex virus (HSV) and research efforts to develop a vaccine. Dr. Lawrence Corey from the University of Washington presents recent data on HSV reactivation and shedding, along with a short history of HSV vaccine development. Dr. Lawrence Corey
Presentations and discussion session. Presentations: 1) Commitment to the Creation of Sustainable Influenza Vaccine Production Capacity Worldwide by Ms. Christina M. Hartman 2) Development of International Influenza Vaccine Production Capacity: Update of WHO Programme by Dr. Laszlo Palkonyay 3) Progress in Influenza Vaccine Capacity Building in Vietnam by Dr. Rick Bright http://www.globalhealth.gov/topics/vaccineWorkshops/01112010v.html
HIV continues to be the epidemic of our lifetime. Even today, 2 million new infections occur worldwide and there are over 50,000 new cases a year in the US. Developing an HIV vaccine has been a scientific challenge, but new technologies and approaches are leading to guarded optimism about achieving this goal. Dr. Lawrence Corey, professor of medicine and laboratory medicine at the University of Washington, past president of the Fred Hutchinson Cancer Research Center, and head of the HIV Vaccine Trials Network, will discuss the state of the HIV vaccine field and the role Seattle plays in this field. Lawrence Corey, MD, professor, Departments of Medicine and Laboratory Medicine, adjunct professor, Departments of Pediatrics and Microbiology, University of Washington 03/30/2016 http://depts...
World Vaccine Congress & Expo 2013 Dr. Peter Collins, Chief of RNA Virus Section, NIAID at NIH gives his presentation on 'RSV vaccines: developing an effective vaccine'. The World Vaccine Congress & Expo is now in its 13th year and is the biggest and most comprehensive event for the industry. Covering everything from the latest R&D; to manufacturing to the corporate development strategies you'll be sure to find answers to all your questions. Visit our Website: http://www.terrapinn.com/2013/world-vaccine-congress-washington/index.stm Read our blog: http://blogs.terrapinn.com/vaccinenation/ Follow us on Twitter: @vaccinenation Join our Linkedin group: http://www.linkedin.com/groups/Vaccine-Nation-1351197
Toward a Universal Influenza Virus Vaccine Air date: Wednesday, April 30, 2014, 3:00:00 PM Category: Wednesday Afternoon Lectures Runtime: 00:51:42 Description: Wednesday Afternoon Lecture Series Because influenza viruses are constantly changing, it's difficult to develop effective vaccines against them. Two molecules on the surface of the virus control its infectivity: hemagglutinin and neuraminidase. Current influenza virus vaccines predominantly elicit a protective immune response to the immunodominant but variable head of the hemagglutinin. This approach is effective, especially when the vaccine strain closely matches the circulating virus. Another vaccine strategy involves redirecting the response to the more conserved stalk domain of the hemagglutinin and the immunosubdominant...
How can we use new understandings of HIV to develop a vaccine to prevent AIDS? And how do we evaluate which HIV vaccine strategies to pursue? Dr. Nicole Frahm, associate lab director of the HIV Vaccine Trials Network, will share the latest findings with you from the largest public-private partnership dedicated to finding an HIV vaccine.
In this informative talk, Bruce Walker, investigator for the Howard Hughes Medical Institute and director for the Center for AIDS research, discusses efforts to develop an effective vaccine against HIV. Despite decades of research, scientists have not closed in on developing a much-needed vaccine for HIV. A key challenge is how to address the rapid evolution of the virus within individuals, which makes it difficult to pinpoint a stable protein sequence for vaccine development.
Infection and Host Response: From Basic Research to Global Health "Industry-University Roundtable: Partnering to Develop Vaccines for Global Health" Panelists: David Cook, PhD, Chief Executive Officer, Anza Therapeutics John Mekalanos, PhD, Professor, Harvard Medical School Carol Mimura, PhD, Assistant Vice Chancellor, Intellectual Property and Industry Research Alliances Rino Rappuoli, PhD, Novartis Vaccines and Diagnostics Moderated by Daniel Portnoy, PhD, Professor, Molecular and Cell Biology, UC Berkeley Recorded 12 December 2008 Center for Emerging and Neglected Diseases http://cend.berkeley.edu
A lecture by Dan Barouch, professor of medicine at Harvard Medical School and director of the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center Molecular science has revolutionized the approach to vaccine and drug development. The goal of this lecture is to describe the current state of the HIV epidemic and the prospects for developing a vaccine or a cure for this disease. Introduced by Janet Rich-Edwards, codirector of the Science Program, Radcliffe Institute; associate professor of medicine, Harvard Medical School; associate professor, Department of Epidemiology, Harvard T.H. Chan School of Public Health
This was a lecture given by Dr Vinodh Kurella a researcher at the Harvard medical school to students and faculty of the Biomedical engineering department of the university of Ghana.
Professor John Barton of Stanford University gave this presentation to members of the Intellectual Property Association at Santa Clara University on January 24, 2006. NOTE - This video can only be used for educational purposes. Adam Marcus speaker: John Barton
Boris Minev, M.D., Assistant Project Scientist, UCSD Cancer Center discusses new strategies for the development of cancer vaccines in this presentation by Stein Institute for Research on Aging. Series: "SIRA (Sam and Rose Stein Institute for Research on Aging)" [6/2002] [Health and Medicine] [Show ID: 6003]
Dr Maximillian Habibi, Imperial College London Topics in Infection 2016 Thursday, 4 February 2016 Brunei Gallery, SOAS, University of London https://rstmh.org/
Paul Fine, Professor of Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, delivers a lecture on the history of vaccination and its role in public health to the first Public Health England Annual Conference in 2013.
The Fat Virus tells the remarkable story of a doctor from India who discovered the existence of an 'obesity virus'. The exclusive story of Nikhil Dhurandhar's controversial discovery, which he claims is responsible for weight gain in up to 30 percent of people who are seriously fat, has swept into the heart of America's most emotive, political and urgent medical crisis - one that is rapidly taking over the rest of the world. Following initial scepticism from the medical establishment, he has now secured sufficient backing to develop a vaccine. Content Provided By DRG. Any Queries please contact us at hello@littledotstudios.com Subscribe to Spark for more amazing science, tech and engineering videos - https://goo.gl/LIrlur
The risks of vaccines are very real, and parents are allowed to question their safety. This documentary discusses the science and history behind the vaccine industry... Sign-up now to watch more episodes: http://bit.ly/jan-ttav-signup-yt You can own every single interview from start to finish (54 total) as well as the entire “Director's cut” of the docu-series (100+ additional minutes) for a very low investment. Follow this link to find out more: http://bit.ly/jan-ttav-dvd-yt Or sign up to watch all 7 episodes of “The Truth About Vaccines” for FREE starting January 25 at 9pm EST: http://bit.ly/jan-ttav-signup-yt ----------------------------------------------------------------------------------------------------------- In Episode 1: The History of Vaccines, Smallpox, Vaccine Safety & th...
Biomedical research towards the prevention and treatment of HIV, tuberculosis, malaria, and other major global health challenges remains our long-term hope for bringing these epidemics to an end. Understanding when new technologies are likely to emerge from the research and development pipeline, and how they might impact ongoing efforts, is vital to ensuring their rapid uptake and integration. Please join us for a discussion on the status of HIV vaccines and how the U.S. will need to change its response to the global epidemic. Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Disease (NIAID), will deliver the keynote address. Afterwards, Dr. Fauci will join a distinguished panel with Mr. Mitchell Warren, Executive Director of AVAC, a New York-based advocacy...
Nobel Laureate Professor Rolf Zinkernagel presented a Public Lecture at the The John Curtin School of Medical Research (JCSMR) at ANU on 25 August 2014 entitled 'Why do we not have a vaccine against HIV or TB?' Prior to the public lecture the Curtin Medal for Excellence in Medical Research for 2013 was awarded to the Swiss Nobel Laureate for a lifetime achievement in immunology. Professor Zinkernagel, who spent 34 years at the University of Zurich, was a Visiting Fellow at The John Curtin School of Medical Research (JCSMR) during the early 1970s, where his research with Professor Peter Doherty won the pair a Nobel Prize in 1996. The Prize was for their discoveries concerning the specificity of the cell mediated immune defence. Professor Zinkernagel said he was honoured to be recognised...
Presentations and discussion session. Presentations: 1) Pandemic A(H1N1) 2009 Vaccine Production: Preliminary 2010 Survey Results by Dr. Marie-Paule Kieny 2) Overview of Current Vaccine Manufacturing Capacity in Developing Countries: Existing Infrastructure: Current Status at SIIL/Pune for Pandemic Influenza Vaccine by Dr. Suresh Jadhav http://www.globalhealth.gov/topics/vaccineWorkshops/01112010v.html